To include your compound in the COVID-19 Resource Center, submit it here.

Kymera raises $30M series A

Kymera Therapeutics LLC (Cambridge, Mass.) raised $30 million in a series A round led by co-founder investor Atlas Venture. New investors Lilly Ventures and Amgen Ventures participated in the

Read the full 296 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE